Navigation Links
TetraLogic Pharmaceuticals Announces New Executives
Date:8/19/2013

MALVERN, Pa., Aug. 19, 2013 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule SMAC mimetic drugs to treat cancer, today announced the appointment of a new senior executive leadership team with the goal of accelerating the development of the company and its lead product candidate birinapant. The new TetraLogic senior executives are J. Kevin Buchi, President and Chief Executive Officer, Pete A. Meyers, Chief Financial Officer, and Lesley Russell, MBChB, MRCP, Chief Operating Officer.  John M. Gill, the departing President, Chief Executive Officer and Co-founder of TetraLogic, will continue to serve on the company's Board of Directors.

"I am pleased to hand over the reins to Kevin who is a highly regarded leader within our industry," stated Mr. Gill. "Together with Pete Meyers and Lesley Russell, this team represents the ideal complement to the existing team at TetraLogic, bringing the expertise and experience we need to maximize the value of our lead SMAC mimetic drug candidate birinapant, grow the company, and realize the full economic potential of our commercial opportunities for our shareholders."

"I am honored to be chosen to lead TetraLogic at this very exciting time for the company," stated Mr. Buchi. "With a strong team and clear leadership position in SMAC mimetics, we have a tremendous opportunity to continue the momentum established for birinapant as a potential treatment for both solid tumors and hematological malignancies. Having spent most of my career in the biotech industry, I have a strong sense of the opportunities for success at TetraLogic and look forward to leading the company into what promises to be an exciting future."

Mr. Buchi was most recently Corporate Vice Presi
'/>"/>

SOURCE TetraLogic Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015 Following announcements from ... transactions, Array BioPharma Inc. (NASDAQ:  ARRY) today announced ... definitive agreements with Novartis.  Along with global ownership ... payment of $85 million from Novartis. ... the close of the Novartis-GSK transaction, Array now ...
(Date:3/2/2015)... NEW YORK , March 2, 2015  Delcath ... pharmaceutical and medical device company focused on oncology with ... liver cancers, announces that Company management will participate in ... held from March 8-11, 2015 at the Ritz Carlton ... Jennifer Simpson , PhD, MSN, CRNP, Delcath,s ...
(Date:3/2/2015)... According to statistics released by the American Society of Plastic ... such as the JUVEDERM ® family of fillers continues ... 2013 to 2014, HA filler treatments increased by 8 percent. ... shows U.S. unit sales of HA dermal fillers were up ... findings are consistent with what I see every day in ...
Breaking Medicine Technology:Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5Delcath To Present At The 27th Annual Roth Conference 2Delcath To Present At The 27th Annual Roth Conference 3Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 2Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 3Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 4Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 5Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 6Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 7
... Corporation, a leading developer of whole blood analyzers, today ... CBGM, LLC, has completed the acquisition of certain assets ... , Nova Biomedical is the sole manufacturer, ... (CBGM) subsidiary has become the exclusive distributor, of the ...
... Oct. 7 DATATRAK International, Inc. (OTCQX: DATA), a technology ... clinical trials industry, today announced the signing of a new ... use of a thoracic stent graft in aneurysm repair. ... use of minimally invasive surgical techniques for thoracic aortic aneurysms. ...
Cached Medicine Technology:Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medical's Subsidiary, Sanvita, Inc. 2DATATRAK Signs 6 Year Study with New Device Client 2DATATRAK Signs 6 Year Study with New Device Client 3
(Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
(Date:3/2/2015)... York, New York (PRWEB) March 02, 2015 ... Creative Recovery at Recovery Unplugged™—will be delivering a ... A Singer/Songwriter's Perspective on the Art of Healing ... Addiction Disorders (NCAD) and Behavioral Healthcare Executive Summit ... his name, Mr. Supa’s songs have been recorded ...
(Date:3/2/2015)... the last five years the ultrasound market has witnessed ... geographic presence and achieve economies of scale. The global ... 2019 at CAGR of 5.1% from 2014 to 2019 ... a major part of Europe are mature markets for ... China and India, Latin America and the Middle East ...
(Date:3/2/2015)... The minimally invasive surgical instruments ... of 6.1% to reach $14,133.0 million by 2019 ... such as advantages of minimally invasive surgeries over ... minimally invasive surgeries and increasing number of surgical ... global minimally invasive surgical instruments market. , For ...
(Date:3/2/2015)... 02, 2015 LegitScript, LLC, ... certification programs, including those for Internet pharmacy ... safety and classification, has launched a certification ... The new program, called iCareRx , ... regarding the identity of the owner/operator of ...
Breaking Medicine News(10 mins):Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2
... announced the discovery of another gene responsible for late-onset ... the disease (occurring in around 90 percent of patients) ... Boston University, the University of Toronto, and Columbia University ... in Nature Genetics. ,The reasearchers spent ...
... oral chemotherapy in US cancer centres need to be improved, ... ,Common malignancies can be treated with oral chemotherapy – a ... ,Researchers from Boston set out to analyse ... the provision of oral chemotherapy. Forty-two centres took part in ...
... research team works on understanding the heart's natural ... Cardiac Electrophysiology Lab, //she is a faculty member ... subtle rhythms, pulses and patterns of the human ... for millennia, yet the heart's deepest secrets remain ...
... rest on the couch to recover before returning to sports, ... at least not yet. // ,One Ohio State University ... devices for the heart will be put to use temporarily ... Right now, such heart pumps, known commonly as ventricular assist ...
... exposure may differ across Australia, a senior cancer researcher has ... for the production of vitamin D, which is necessary for ... prevention of several cancers. ,Australians are becoming ... out of the sun to avoid skin cancer and getting ...
... Kennedy Center for Research on Human Development has observed ... behavioral //and neurological problems in the child. ,In ... Stanwood, Ph.D., and Pat Levitt, Ph.D., have elaborated about ... which caused a prolonged displacement of dopamine receptors in ...
Cached Medicine News:Health News:New Gene to Help in Understanding Alzheimer’s Diseas 2Health News:Secrets of the Heart's Signals 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 3Health News:Safe Sun Exposure a Burning Issue 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 3
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
Medicine Products: